AWH - חוב לטווח קצר להון Aspira Women's Health

Aspira Women's Health (AWH) is optimizing the nationwide delivery of biomaterials through a partner network, which supports high margins. The business focuses on ovarian cancer detection using OvaWatch and Ova1Plus, aiming to expand insurance coverage. The market trend for the individual debt-to-equity ratio is 0.00. The implementation of OvaSuite systems provides an immediate effect, while future growth depends on the development of health insurance and R&D.

Assessing the debt load of Aspira Women's Health (AWH) through the ratio of short-term liabilities (up to one year) to equity helps identify liquidity risks, which is critical for a company whose stability is based on demand for medical innovations that remains independent of macroeconomic trends; by analyzing the dynamics of short-term liabilities to equity, an investor determines the balance between utilizing borrowed funds for growth and the threat of a cash crunch.